EYES News and Press, Second Sight Medical Products Inc. From 05/15/19

Second Sight (NASDAQ: EYES ): Q1 Non-GAAP EPS of -$0.07 misses by $0.01 ; GAAP EPS of -$0.10 misses by $0.03 . More news on: Second Sight Medical Products, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

-- Company to Accelerate Development of Orion ® Visual Cortical Prosthesis System -- Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are i...

-- Positive Results of Early Feasibility Study and Significant Market Potential Drive Refined Strategy -- -- Company to Provide Continued Support for Existing Argus ® II Users Worldwide -- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” ...

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, will release its financial results for the first quarter of 2019 on Wednesday, M...

ATA (NASDAQ: ATAI ) -21% . More news on: ATA Inc., Marathon Patent Group, Inc., Bed Bath & Beyond Inc., Stocks on the move, Read more ...

Thinly traded micro cap Second Sight Medical Products (NASDAQ: EYES ) slips  11%  premarket on increased volume in reaction to its update on its early feasibility study of the Orion Visual Prosthesis System designed to create an artificial form of useful vision for the blind. The...

-- Presentation to Provide Update of Early Feasibility Study of the Orion ® Visual Prosthesis System -- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable vis...

Second Sight Medical Products, Inc. (EYES) Q4 2018 Earnings Conference Call March 13, 2019 4:30 PM ET Company Participants Lisa Wilson - Investor Relations Will McGuire - President & Chief Executive Officer John Blake - Chief Financial Officer Conference Call Participants ...

Second Sight (NASDAQ: EYES ): Q4 Non-GAAP EPS of -$0.10 beats by $0.01 ; GAAP EPS of -$0.12. More news on: Second Sight Medical Products, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today reported fin...